As of 2026-03-16, the Relative Valuation of Ionis Pharmaceuticals Inc (IONS) is (36.26) USD. This relative valuation is based on P/E multiples. With the latest stock price at 71.19 USD, the upside of Ionis Pharmaceuticals Inc based on Relative Valuation is -150.9%.
The range of the Relative Valuation is (39.09) - (40.74) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.9x - 17.3x | 13.6x |
| Forward P/E multiples | 16.6x - 17.8x | 17.2x |
| Fair Price | (39.09) - (40.74) | (36.26) |
| Upside | -154.9% - -157.2% | -150.9% |
| Date | P/E |
| 2026-03-13 | -30.23 |
| 2026-03-12 | -30.72 |
| 2026-03-11 | -31.76 |
| 2026-03-10 | -32.13 |
| 2026-03-09 | -32.00 |
| 2026-03-06 | -31.44 |
| 2026-03-05 | -31.92 |
| 2026-03-04 | -33.74 |
| 2026-03-03 | -33.41 |
| 2026-03-02 | -34.81 |
| 2026-02-27 | -34.46 |
| 2026-02-26 | -34.23 |
| 2026-02-25 | -34.37 |
| 2026-02-24 | -36.29 |
| 2026-02-23 | -35.93 |
| 2026-02-20 | -35.31 |
| 2026-02-19 | -35.31 |
| 2026-02-18 | -34.92 |
| 2026-02-17 | -34.55 |
| 2026-02-13 | -34.23 |
| 2026-02-12 | -34.73 |
| 2026-02-11 | -35.82 |
| 2026-02-10 | -35.80 |
| 2026-02-09 | -36.01 |
| 2026-02-06 | -36.74 |
| 2026-02-05 | -35.45 |
| 2026-02-04 | -36.09 |
| 2026-02-03 | -35.92 |
| 2026-02-02 | -35.28 |
| 2026-01-30 | -35.11 |
| 2026-01-29 | -35.62 |
| 2026-01-28 | -34.79 |
| 2026-01-27 | -34.88 |
| 2026-01-26 | -34.40 |
| 2026-01-23 | -34.10 |
| 2026-01-22 | -34.74 |
| 2026-01-21 | -33.74 |
| 2026-01-20 | -32.93 |
| 2026-01-16 | -32.42 |
| 2026-01-15 | -32.79 |
| 2026-01-14 | -33.50 |
| 2026-01-13 | -33.75 |
| 2026-01-12 | -34.68 |
| 2026-01-09 | -34.10 |
| 2026-01-08 | -34.63 |
| 2026-01-07 | -35.32 |
| 2026-01-06 | -34.61 |
| 2026-01-05 | -33.35 |
| 2026-01-02 | -33.83 |
| 2025-12-31 | -33.60 |